Lanean...
Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers
OBJECTIVES. Stage I, grade 1 endometrial cancers have low recurrence rates and often do not receive adjuvant therapy. We compared recurrent cases to matched non-recurrent controls to evaluate for molecular markers associated with higher risk of recurrence. METHODS. A case-control study including all...
Gorde:
| Argitaratua izan da: | Gynecol Oncol |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7005911/ https://ncbi.nlm.nih.gov/pubmed/30910249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2019.03.100 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|